LATAM Fusion Biopsy Market Size & Outlook, 2026-2034


LATAM Fusion Biopsy Market Insights

  • As highlighted in Reed Intelligence analysis, the LATAM Fusion Biopsy Market, valued at USD 91.19 Million in 2025, is estimated to achieve USD 221.9 Million by 2034.
  • The market is estimated to grow at a CAGR of 10.28% spanning 2026 to 2034.
  • By market size, MRI-Ultrasound Fusion Biopsy led the By Type category in 2025.
  • The By Type segment led by Cognitive Fusion Biopsy is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • LATAM held 5.01% share of the global Fusion Biopsy Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, Argentina is anticipated to record the highest growth in LATAM, with the market size expected to reach USD 23.63 Million.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 91.19 Million
Market Size In 2034 USD 221.9 Million
Largest segment MRI-Ultrasound Fusion Biopsy
Units Revenue in USD Million
CAGR 10.28% (2026-2034)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
By Type
  1. MRI-Ultrasound Fusion Biopsy
  2. Cognitive Fusion Biopsy
  3. Transperineal Fusion Biopsy
By Application
  1. Prostate Cancer Diagnosis
  2. Focal Therapy Planning
  3. Active Surveillance Monitoring
By End Use
  1. Hospitals
  2. Diagnostic Imaging Centers
  3. Ambulatory Surgical Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
clients
Trusted by Fortune 500
Over 30000+ subscribers